注射用设备及产品市场:2023年

本报告提供全球注射用设备及产品市场相关调查，各市场区隔概要，新兴技术，市场分析与预测，及加入此市场的主要企业简介等资讯。

目录

摘要整理

单回用量固定型

• Molly(SHL Medical)
• Molly RNS(SHLMedical)
• Belta(SHL Medical)
• Maggie(SHL Medical)
• Amber(SHL Medical)
• AutoJect 2(Owen Mumford)
• SelfDose(West Pharmaceutical Services)
• DAI(SHL Medical)
• DI 2(SHL Medical)
• Flexi-Q PFS(Elcam Medical)
• fijiojekuto(Becton Dickinson
• intebia(Becton Dickinson)

可变用量型

• VSDI+NIT
• Ypsomed VarioJect

高粘度型

• Rotaject Technology(SHL Medical)
• 再利用笔
• 双心腔型笔

商务用笔产品

• GENOTROPIN Pen
• Humatro-Pen/Humatro Pen 3
• Norditropin
• NordiPenmate
• Nutropin AQ Pen
• Omnitrope
• One.Click
• Lantus/Toujeo(Insulin Glargine)
• Diapen
• Gansulin Pen
• Flexpen (Novo Nordisk)
• Humalog Pen/KwikPen
• HumaPen Memoir
• HumaPen Luxura HD
• NovoPen (Novo Nordisk)
• SoloStar
• Byetta Pen
• Bydureon
• SymlinPen
• Saxenda (Liraglutide)
• Tanzeum (Abliglutide)
• Trulicity (Dulaglutide)
• Victoza (Liraglutide)

副甲状腺素用

• Forteo Pen
• Preotact/Preos
• Natpara

生殖荷尔蒙用

• Follistim/Puregon Pen
• Gonal-f

穿戴式设备- 分析与评估

• Libertas (Becton Dickinson)
• SmartDose (West Pharmaceuticals)
• Neulasta OnPro Injector (Insulet/Amgen)
• YpsoDose (Ypsomed)
• Electronic Semi-disposable
• eLVD Patch Pump (Elcam)
• Ypsomed/Ypsomed 2.25)
• Flexi-Q HV (Elcam Medical)

双心腔型型

• SDI MIX+NIT(SHL Medical)

无线支援自动注射器

• BETACONNECT (Bayer)
• RebiSmart (Merck Serono)

产品固有的自动注射器

• Alsuma/Sumatriptan Autoinjector
• Sumatriptan (Dr. Reddy's)
• Rebif/Rebidose (Merck Serono)
• Aimovig (Amgen/Novartis)
• Enbrel Mini AutoTouch (Amgen)
• Pegasys Proclick (Genentech/Roche)
• Otrexup (Antares Pharma)
• Evzio (Kaleo)

自动注射器的设计要素

• 材料选择的问题
• 零件分数和设备成本
• 安全功能
• 针插入深度
• 故障保险装置活化
• 给药检验、注射确认

市场要素

• 冷冻干燥药/重组
• 人因工程/人体工学

笔型注射器

• 笔型注射器的设计选择要素
• 标准化笔平台
• Haselmeier
• Becton Dickinson
• Owen Mumford
• Autoject2
• Ypsomed
• SHL Medical
• 自订笔设计

新兴技术

• 无线资料

注射剂市场分析与预测

• 自体免疫疾病
  • 类风湿性关节炎
  • 干癣
  • 多发性硬化症
• 造血
  • 荷尔蒙
  • 骨质疏鬆症
  • 妊娠能力

市场要素

• 法规上的问题
• 设备的品牌
• 患者的医嘱遵从性与易用性
• 医疗保健经济学

企业简介

“Injectable Drug Devices and Products - 2023” is a comprehensive evaluation and analysis of the technology, products and participants providing the driving force behind this evolving segment of the healthcare sector. The study is designed to provide drug company decision makers, drug delivery developers, device designers, healthcare marketers, and supply chain participants with a detailed understanding of the economics, technologies, disease segments, and commercial opportunities for injection devices. Provider organization business managers, healthcare administrators and investors will also benefit from this study.

Evolution in Therapeutic Care

Because of the ongoing need for repeat dosing posed by chronic diseases, these indications represent significant drug volume and revenue opportunities, while simultaneously challenging the industry to develop products that meet the unique needs of the non-professional caregiver. For drugs designed to be administered by the patient, therapy-specific packaging is improving adherence and treatment outcomes. In the area of delivery, reusable injection devices designed to accept prefilled syringes or drug cartridges are improving ease-of-use and increasing the alternative device share of the growing self-injection market.

What You Will Learn:

• Provides detailed analysis of injectable drug products, drug delivery and device strategies, and product development factors.

• Assesses key markets, market dynamics and market demographics.

• Analyzes therapeutic demand drivers and evaluates injectable drug products in nine key therapeutic segments.

• Provides market data and forecasts.

• Profiles market sector participants, their product development activities, business strategies, and corporate alliances and affiliations

• Assesses the importance of alliances and partnerships on drug product commercialization.

• Evaluates the impact of economic, technology, and regulatory factors.

Table of Contents

Executive Summary

• The Market Opportunity
• Delivery Market Dynamics
• The Economics of Injectable Drugs
• What's Driving the Growth in Injectable Devices?
• Prefilled Syringes Proliferating
• The Prefilled Syringe Supply Chain
• The Trend toward Self-Administration
• Shifting Demographics
• Innovation in Disposable Device Designs
• Proliferation of Biological Drugs
• Therapeutic Monoclonal Antibodies
• Risk Factors
• Injectable Drug Device Summaries
• Autoinjectors

Single Fixed Dose

• Molly (SHL Medical)
• Molly RNS (SHLMedical)
• Bertha (SHL Medical)
• Maggie (SHL Medical)
• Amber (SHL Medical)
• AutoJect 2 (Owen Mumford)
• SelfDose (West Pharmaceutical Services)
• DAI (SHL Medical)
• DI 2 (SHL medical)
• Flexi-Q PFS (Elcam Medical)
• Physioject (Becton DIckinson
• Intevia (Becton Dickinson)

Variable Dosing

• VSDI + NIT
• Ypsomed VarioJect

High Viscosity

• Rotaject Technology (SHL Medical)
• Reusable Pens
• Dual Chamber Pens

Commercial Pen Products

• Genotropin Pen
• Humatro-Pen/Humatro Pen 3
• Norditropin
• NordiPenmate
• Nutropin AQ Pen
• Omnitrope
• One.Click
• Lantus/Toujeo (Insulin Glargine)
• Diapen
• Gansulin Pen
• Flexpen (Novo Nordisk)
• Humalog Pen/KwikPen
• HumaPen Memoir
• HumaPen Luxura HD
• NovoPen (Novo Nordisk)
• SoloStar
• Byetta Pen
• Bydureon
• SymlinPen
• Saxenda (Liraglutide)
• Tanzeum (Abliglutide)
• Trulicity (Dulaglutide)
• Victoza (Liraglutide)

Parathyroid Hormone

• Forteo Pen
• Preotact/Preos
• Natpara

Reproductive Hormones

• Follistim/Puregon Pen
• Gonal-f

Wearable Devices - Analysis and Assessments

• Libertas (Becton Dickinson)
• SmartDose (West Pharmaceuticals)
• Neulasta OnPro Injector (Insulet/Amgen)
• YpsoDose (Ypsomed)
• Electronic Semi-disposable
• eLVD Patch Pump (Elcam)
• Ypsomed/Ypsomed 2.25)
• Flexi-Q HV (Elcam Medical)

Dual Chamber

• SDI MIX +NIT (SHL Medical)

Wirelessly Enabled Autoinjectors

• BETACONNECT (Bayer)
• RebiSmart (Merck Serono)

Selected Product Specific Autoinjectors

• Alsuma/Sumatriptan Autoinjector
• Sumatriptan (Dr. Reddy's)
• Rebif/Rebidose (Merck Serono)
• Aimovig (Amgen/Novartis)
• Enbrel Mini AutoTouch (Amgen)
• Pegasys Proclick (Genentech/Roche)
• Otrexup (Antares Pharma)
• Evzio (Kaleo)

Autoinjector Device Design Factors

• Material Selection Issues
• Part Counts and Device Cost
• Safety Features
• Needle Insertion Depth
• Failsafe Activation
• Dose Inspection/Injection Confirmation

Market Factors

• Lyophilized Drugs/Reconstitution
• Human Engineering/Ergonomics

Pen Injectors

• Pen Injector Design Selection Factors
• Standardized Pen Platforms
• Haselmeier
• Becton Dickinson
• Owen Mumford
• Autoject2
• Ypsomed
• SHL Medical
• Custom Pen Designs

Emerging Technology

• Wireless Data

Injectable Drug Market Analysis and Forecasts

• Autoimmune Diseases
  • Rheumatoid Arthritis
  • Psoriasis
  • Multiple Sclerosis

• Hematopoietics
  • Hormones
  • Osteoporosis
  • Fertility

Market Factors

• Regulatory Issues
• Device Branding
• Patient Adherence and Ease of Use
• Healthcare Economics

Company Profiles